doi: 10.1210/clinem/dgad395
For example, patients who start with a BMI of 55 or above are at greater risk of significant weight regain after VSG and may require GLP-1 medications after VSG to achieve lasting results
Gonzalez de Vega R, Fernandez-Sanchez ML, Fernandez JC, Alvarez Menendez FV, Sanz-Medel A
The labeling, packaging, and specification changes are managed to suit brand positioning and regulatory requirements
It has been widely studied in clinical settings and is often recommended for people who have struggled to lose weight through diet and exercise alone
The co-primary endpoints were percent change from baseline in body weight and proportion of patients achieving 5% additional weight loss (i.e., beyond that already achieved by the lifestyle intervention)